Related Experiment Video
Updated: May 10, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry Data
Pedro Miranda Afonso1,2, Dimitris Rizopoulos1,2, Anushka K Palipana3,4
1Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands.
This study introduces a new Bayesian joint model to analyze complex survival data, including recurrent and competing events, and bounded biomarkers. The model provides more precise insights into disease progression and biomarker associations.
Area of Science:
- Biostatistics
- Longitudinal Data Analysis
- Survival Analysis
Background:
- Joint models for longitudinal and survival data are popular but struggle with complex data structures like recurrent and competing events.
- Existing models often assume Gaussian distributions for biomarkers, which is unsuitable for bounded markers, leading to biased results.
- Handling multiple bounded longitudinal markers alongside recurrent and competing events in a single model is challenging.
Purpose of the Study:
- To propose a novel Bayesian shared-parameter joint model.
- To accommodate multiple (possibly bounded) longitudinal markers, recurrent events, and competing risks simultaneously.
- To improve the analysis of complex survival data and biomarker associations.
Main Methods:
- Developed a Bayesian shared-parameter joint model.
- Utilized the beta distribution for bounded longitudinal markers.
- Incorporated recurrent event processes and competing risks.
- Modeled various association forms, discontinuous risk intervals, and gap/calendar timescales.
Main Results:
- A simulation study demonstrated superior performance compared to simpler joint models.
- The model was applied to the US Cystic Fibrosis Foundation Patient Registry.
- Quantified associations between lung function, BMI, and pulmonary exacerbations, accounting for competing risks of death and transplantation.
Conclusions:
- The proposed model effectively handles complex survival data with multiple bounded markers and competing risks.
- It offers more precise insights into disease progression, as shown in the Cystic Fibrosis Foundation Patient Registry analysis.
- The efficient implementation in the R package JMbayes2 facilitates complex analyses.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Kaplan-Meier Approach
Assumptions of Survival Analysis
Longitudinal Studies
Statistical Methods for Analyzing Epidemiological Data
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...

